Purpose This study aims to analyse the importance of intellectual capital (IC) in networks formed by start-ups, with a view to obtaining resources that individually they would be unable to acquire. Design/methodology/approach To achieve this aim, a qualitative approach was adopted, and within this, the case study method was used. The data-collecting instrument was the semi-structured interview, held with the business-people/managers of five start-ups present in an incubator (Startup Rém) based in Portugal, and with the person in charge of this incubator, together with observation and documentary analysis. Findings From content analysis, the results suggest that the business people recognise the presence of IC at the moment of creating their business and that this is a means to attain sustainability and, consequently, business survival. The results also show that in the absence of network formation, the relation between the incubator and the incubated firms can be affected and limited, interfering directly with firms’ use of IC. Practical implications This research aimed to highlight the importance of IC as an essential resource for business survival and sustainability and to encourage start-ups to regard networks as a way to share and convey knowledge. This study also intends to help firms understand the role of cooperation and mutual assistance in seeking sustainability and economic growth. Originality/value This study is innovative because it has filled the gaps identified in the literature, particularly the absence of studies on the importance of IC in networks formed by start-ups, and the study of the impact of IC on firms focussing on cooperation networks.
BACKGROUND Brain-computer Interface (BCI) is an emerging neurotechnology with potential applications primarily for neurological disorders. There is a rising interest in the clinical use of BCI to improve quality of care. Despite their therapeutic potential, BCI use is still mostly limited to research stages and its translation into mainstream clinical applications and widespread adoption is lagging. OBJECTIVE This study revises the current potential clinical applications of BCIs in humans, attempts to understand barriers and opportunities to wider clinical adoption of this radical innovation in neurological-related care and draws its health policy and management implications. METHODS The methodology followed a two-step approach which included a systematic review of potential clinical applications of BCIs and a qualitative study, using focus group method, to understand and integrate professionals’ experiences, perceptions, thoughts and feelings on the wide clinical adoption of BCIs. The systematic review aimed to review potential relevant clinical applications of BCIs and included 25 studies, published from 2017 to 2021. The qualitative study included 3 focus groups with a total of 22 participants from medical, engineering and management fields. RESULTS Clinical evidence of BCI applications included predominantly neurorehabilitation with non-invasive devices and the control of assistive devices with invasive BCIs (e.g., upper limb rehabilitation in stroke patients or control of spelling systems in LIS patients). Several barriers to wider clinical adoption of BCIs were identified, mostly these were technological barriers like materials biocompatibility and insulation, miniaturization, wireless interfaces and batteries, advanced signal processing and recalibration. Nowadays, with the current pace of technological development, these technological barriers seem addressable in the near future. However, to achieve mainstream clinical applicability, BCIs will have to deal with systemic barriers to innovation in healthcare ecosystem. A comprehensive and multidisciplinary approach will be needed to integrate and adopt BCIs in clinical contexts. CONCLUSIONS The successful integration of BCIs into clinical practice requires a multifaceted approach that addresses various barriers. This includes ensuring the clinical relevance of BCIs, securing funding and addressing potential negative impacts. It is essential to engage with end-users to understand their needs and perspectives and to work collaboratively across private and public institutions to create opportunities for the widespread use of BCIs. The involvement of medical doctors and the development of clinical guidelines will also be crucial for the adoption of BCIs. Ultimately, a concerted effort to engage with a wide range of stakeholders and to foster confidence and support for these devices will pave the way for progress in healthcare contexts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.